Dana E Selley

Title: Dana E Selley: Innovator in Opioid Research

Introduction

Dana E Selley is a prominent inventor based in Richmond, VA (US). She has made significant contributions to the field of opioid research, focusing on developing innovative solutions to mitigate the adverse effects associated with opioid use. With a total of 6 patents, her work is paving the way for safer pain management alternatives.

Latest Patents

Dana's latest patents include groundbreaking developments in nanoparticle conjugated synthetic opioid prodrugs. These prodrugs are designed to target the peripheral mu opioid receptor (MOR) and exhibit long-lived bioavailability. Importantly, they do not compromise the analgesic effects of opioids administered for pain relief and can even be utilized for pain management. Additionally, these prodrugs help prevent and treat unwanted opioid-induced side effects, such as opioid-induced constipation (OIC). Another notable patent involves potent and selective mu opioid receptor modulators. These analogues of 6 α/β-naltrexamine (NAQ) serve as selective, reversible antagonists of the mu opioid receptor, demonstrating good blood-brain barrier penetration. They are intended for use in treating opioid addiction and other related conditions, including pain management.

Career Highlights

Dana E Selley is affiliated with Virginia Commonwealth University, where she continues her research and innovation in opioid therapies. Her work has garnered attention for its potential to revolutionize pain management and addiction treatment.

Collaborations

Dana collaborates with esteemed colleagues, including Yan Zhang and William Dewey, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Dana E Selley's contributions to opioid research exemplify her commitment to improving patient outcomes through innovative solutions. Her patents reflect a deep understanding of the complexities of opioid use and the need for safer alternatives.